The waiting time for a second mutation: an alternative to the Moran
  model by Schinazi, Rinaldo B.
ar
X
iv
:1
30
6.
69
19
v1
  [
ma
th.
PR
]  
28
 Ju
n 2
01
3
The waiting time for a second mutation: an alternative to the
Moran model
Rinaldo B. Schinazi
University of Colorado, Colorado Springs
October 8, 2018
email: rschinaz@uccs.edu
fax: 1 719 2553605
Abstract The appearance of cancer in a tissue is thought to be the result of two or more successive
mutations. We propose a stochastic model that allows for an exact computation of the distribution of the
waiting time for a second mutation. This models the time of appearance of the first cancerous cell in a tissue.
Our model is an alternative to the Moran model with mutations.
1 The model
The idea of successive mutations to trigger the appearance of a cancerous cell goes back to at least Muller
(1951). The first mathematical model proposed for this phenomenon goes back to Armitage and Doll (1954).
There has been a great deal of discussion on the number of successive mutations necessary to get a cancerous
cell. It seems that this number depends on the organ, see Knudson (1971) and Moolgavkar and Luebeck
(1992) . However, some authors have argued that two mutations models are flexible enough to model most
cancers, see Armitage and Doll (1957) and Moolgavkar and Knudson (1981). This is the point of view we
adopt.
We now describe our model. We are interested in the time it takes for a given organ to have a first
cancerous cell. We assume that all cells are in one of three stages: healthy, pre-cancerous (i.e. type 1) and
cancerous (i.e. type 2). We start the process with all cells healthy. As the cells divide pre-cancerous cells
may appear due to a type 1 mutation on a healthy cell. A type 2 mutation on a pre-cancerous cell makes
the cell cancerous.
The number of type 1 mutations is modeled by a Poisson process with rate µ1N . We think of µ1 as a
mutation rate and N as a division rate. Every time a type 1 mutation appears there is a chance that a type
2 mutation appears. We model the appearance of a type 2 mutation by using exponential random variables
with rate µ2. More precisely, let N1(t) be the number of type 1 mutations that have occurred up to time
t. Let T1 < T2 < . . . be the arrival times of this Poisson process. Given that N1(t) = k and that T1 = t1,
T2 = t2, . . . , Tk = tk let S1, S2, . . . , Sk be random variables with density
P (Si > t|Ti = ti) = exp(−µ2(t− ti)) for t > ti,
and i = 1, . . . , k. We also assume that given T1 = t1, T2 = t2 . . . Tk = tk, the random variables S1, S2, . . . , Sk
are independent. The random variables Si are the times when a type 2 mutation appears. The minimum of
these times (i.e. the first time a type 2 mutation appears in the tissue) is denoted by τ2.
Here is our main result.
Theorem 1. Let τ2 be the time for the first type 2 mutation to appear. Then,
P (τ2 > t) = exp[µ1Nt(−1 +
1− exp(−tµ2)
tµ2
)].
1
Note that
P (τ2 > t) = exp[µ1tf(tµ2)]
N
where f(x) = −1 + 1−exp(−x)
x
.
This shows that our model is equivalent to a model with N independent cells. Observe also that the
function f decreases from 0 to −1 for x in [0,+∞). In particular, µ1 and µ2 do not hold symmetric roles in
the formula. For instance, a small µ1 cannot be compensated by a large µ2.
2 Discussion
Waiting times for successive mutations have been recently studied by several authors using the Moran model
with mutations, see Iwasa et al. (2004) and (2005) and Wodarz and Komarova (2005). A more mathematical
approach is taken by Durrett et al. (2009) and Schweinsberg (2008). The Moran model assumes a fixed
number N of cells. Each cell lives for a mean 1 exponential time and then is replaced by a new cell chosen
at random from one of the N cells. Moreover, a healthy cell mutates into a precancerous cell at rate µ1 and
a precancerous mutates into a cancerous cell at rate µ2. Each new cell has the same number of mutations as
its parent. An attractive feature of the Moran model is that it is defined as a cell based model. A drawback
is that the analysis of the model is quite involved and the only results that can be hoped for are non rigorous
approximations or limits for different configurations of N , µ1 and µ2. In contrast, our model gives an exact
formula for the waiting time distribution.
Our model is not fundamentally different from the Moran model. In particular, in the Moran model
a precancerous cell has equal death and birth rates. Hence, a precancerous cell generates a process which
in average does not gain or lose cells. It turns out that estimating the stochastic fluctuations around this
expected value is quite difficult. In our model we assume instead that a precancerous cell does not die or
give birth, it stays put waiting for a type 2 mutation. Therefore, the expected offspring of a precancerous
cell is also 1 in our model but there are no stochastic fluctuations to estimate.
As a consequence of Theorem 1 we have the following limits. To compute these limits assume that µ1
and µ2 are functions of N .
• Assume that
lim
N→∞
µ2
µ1N
= α ∈ (0,+∞).
Then,
lim
N→∞
P (µ1Nτ2 > t) = exp[t(−1 +
1− exp(−tα)
tα
)].
• Assume that
lim
N→∞
µ2
µ1N
= +∞.
Then,
lim
N→∞
P (µ1Nτ2 > t) = exp(−t).
• Assume that
lim
N→∞
µ1Nµ2 = α ∈ (0,+∞) and lim
N→∞
µ2 = 0.
Then,
lim
N→∞
P (τ2 > t) = exp(−
1
2
αt2).
In particular, the distribution of τ2 exhibits at least three different behaviors depending on the relative
magnitude of µ1, µ2 and N . These limits show a number of similarities with limits found for the Moran
model by Durrett, Schmidt and Schweinsberg (2009) and Schweinsberg (2008).
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Note also that as t approaches 0 (for fixed µ1, µ2 and N)
P (τ2 ≤ t) ∼
1
2
µ1µ2Nt
2.
This is consistent with the model of Armitage and Doll (1954).
3 The proof of Theorem 1
Let N1(t) be the number of type 1 mutations that occurred in the tissue up to time t. Given {N1(t) = k}
no type 2 mutation has occurred (i.e. {τ2 > t}) if and only if none of the k type 2 mutation exponential
random variables have occurred. Denote these k random variables by S1, S2, . . . , Sk. We have
P (τ2 > t|N1(t) = k) = P (S1 > t, S2 > t, . . . , Sk > t|N1(t) = k).
Let T1, T2, . . . , Tk be the arrival times of the Poisson process N1. By definition of the random variables
S1, S2, . . . , Sk we have for i = 1, . . . , k
P (Si > t|Ti = ti) = exp(−µ2(t− ti)) for t > ti.
Given (T1, T2, . . . , Tk) the random variables S1, S2, . . . , Sk are conditionally independent. Hence,
P (τ2 > t|N1(t) = k) =
∫
0<t1<t2<···<tk<t
exp(−µ2(t− t1)) . . . exp(−µ2(t− tk))f(t1, t2, . . . , tk)dt1dt2 . . . dtk,
where f is the density of the random vector (T1, T2, . . . , Tk) conditioned on {N1(t) = k}. A classical Poisson
process result is that this conditional distribution is the order statistics distribution corresponding to k
independent random variables uniformly distributed on (0, t), see for instance Proposition 5.6 in Bhattacharya
and Waymire (1990). Therefore,
P (τ2 > t|N1(t) = k) = exp(−µ2kt)
∫
0<t1<t2<···<tk<t
k!
tk
exp(µ2(t1 + t2 + · · ·+ tk)dt1 . . . dtk.
In order to compute this integral we make the following remark. Let U1, U2, . . . , Uk be independent and
uniformly distributed on (0, t). Let U(1) < U(2) < · · · < U(k) be the corresponding order statistics. We have
that
E[exp(µ2(U(1) + U(2) + · · ·+ U(k)))] =
∫
0<u1<u2<···<uk<t
k!
tk
exp(µ2(u1 + u2 + · · ·+ uk)du1 . . . duk.
Observe that
U(1) + U(2) + · · ·+ U(k) = U1 + U2 + · · ·+ Uk.
Hence,
E[exp(µ2(U(1) + U(2) + · · ·+ U(k)))] = E[exp(µ2(U1 + U2 + · · ·+ Uk))] = E[exp(µ2U1)]
k.
It is easy to compute
E[exp(µ2U1)] =
1
tµ2
(exp(tµ2)− 1).
Therefore,
P (τ2 > t|N1(t) = k) = exp(−µ2kt)[
1
tµ2
(exp(tµ2)− 1)]
k = [
1
tµ2
(1− exp(−tµ2))]
k.
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Now,
P (τ2 > t) =
∞∑
k=0
P (N1(t) = k)P (τ2 > t|N1(t) = k) =
∞∑
k=0
exp(−µ1Nt)
(µ1Nt)
k
k!
[
1
tµ2
(1− exp(−tµ2))]
k.
Summing the series yields
P (τ2 > t) = exp(−µ1Nt) exp[
µ1N
µ2
(1− exp(−tµ2))].
This formula can be rewritten as
P (τ2 > t) = exp[µ1Nt(−1 +
1− exp(−tµ2)
tµ2
)].
The proof of Theorem 1 is complete.
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